C O M M U N I C A T I O N S
Table 1. Dissociation Constants (KD) Determined by SPR and
Stabilization Potential Determined by FRET Melting
significant increase of the band at 265 nm characteristic of a parallel
conformation. This effect was much more pronounced for 1a,b,
which have been found to be the tightest binders by SPR, than for
the weaker binders 1c,d. Addition of the macrocycle to prefolded
hTelo quadruplex did not induce significant change in quadruplex
conformation, even after 3 h, suggesting that conformational
interconversion is slow. This indicates a thermodynamic preference
of macrocycles 1a-d for binding to a parallel G-quadruplex
structure as compared to an antiparallel conformation. The c-kit
quadruplex already exists as a predominantly parallel structure in
K+-containing buffer and showed no significant change in the CD
spectrum upon inclusion of ligands 1a-d (Figure 3, right). These
results are consistent with the preference of the macrocycles 1 for
the predominantly parallel c-kit quadruplex3 as compared to hTelo
which is highly polymorphic. This new class of quadruplex binding
ligands represents a versatile and promising scaffold. Further
optimization of such structures and an evaluation of biological
activity are in progress.
DNA
1a
1b
1c
1d
K
D [µM]
hTelo
c-kit
hTelo
c-kit
15 ( 1
5 ( 2
5.2
10.8
0.0
12 ( 1
4 ( 2
6.4
8.7
0.0
56 ( 11
31 ( 5
4.5
6.1
0.0
53 ( 8
8 ( 3
0.5
1.2
0.7
∆Tm
at 1 µM
[°C]
ds DNA
Figure 2. (left) SPR binding curve for macrocycle 1a to hTelo (9), c-kit
(2), and ds DNA (f); running-buffer, 50 mM Tris‚HCl pH 7.4, 100 mM
KCl. (right) FRET assay for hTelo (9), c-kit (2), and ds DNA (f) in the
presence of 1a; buffer, 60 mM potassium cacodylate pH 7.4.
Acknowledgment. We thank the Gates Cambridge Trust for a
studentship (K.J.) and the Cancer Research U.K. for program
funding (R.R. and S.L.) and the BBSRC for funding (P.S.). S.B. is
a BBSRC Career Development Research Fellow. We also thank
Dr. A. Bugaut for careful reading of the manuscript.
Supporting Information Available: Experimental procedures for
the synthesis of the macrocycles 1, SPR binding curves, experimental
details for CD and FRET. This material is available free of charge via
References
Figure 3. CD spectra of hTelo (left) and c-kit (right) in K+ containing
buffer (50 mM Tris‚HCl pH 7.4, 100 mM KCl): without ligand (black);
folded in the presence of 1a (red), 1b (blue), 1c (green), and 1d (cyan).
(1) Zahler, A. M.; Williamson, J. R.; Cech, T. R.; Prescott, D. M. Nature
1991, 350, 717.
(2) (a) Huppert, J. L.; Balasubramanian, S. Nucleic Acids Res. 2005, 33, 2908.
(b) Todd, A. K.; Johnston, M.; Neidle, S. Nucleic Acids Res. 2005, 33,
2901.
equilibrium binding. For all ligands 1a-d no stabilization of duplex
DNA was observed, which is consistent with the SPR observations
and confirms the high selectivity for G-quadruplex DNA. For
ligands 1a-c the trend for G-quadruplex stabilization effects were
consistent with the KD values obtained by SPR, the tightest binder
inducing the strongest thermal stabilization (Table 1). However,
macrocycle 1d, which binds to hTelo and c-kit with affinities
comparable to that of 1c and 1a, did not induce a significant thermal
stabilization, even at high ligand concentration (up to 50 µM). This
suggests that while 1d binds to c-kit with an affinity comparable
to those of ligands 1a-c, its mode of binding does not stabilize
(or destabilize) the folded c-kit quadruplex structure.
To provide further insight into the mode of binding we have
used circular dichroism (CD) spectroscopy to elucidate ligand
effects on the folded conformations of hTelo. In the absence of the
ligands, the hTelo oligonucleotide coexists in K+-containing buffer
as a mixture of parallel and antiparallel G-quadruplex conformations
exhibiting two maxima at 265 and 291 nm as well as a minimum
at 243 nm (Figure 3, left).12 When hTelo is folded in the presence
of a 10-fold excess of the respective macrocycle 1, a loss of the
antiparallel signal (291 nm) was observed simultaneously with a
(3) Fernando, H.; Reszka, A. P.; Huppert, J.; Ladame, S.; Rankin, S.;
Venkitaraman, A. R.; Neidle, S.; Balasubramanian, S. Biochemistry 2006,
45, 7854.
(4) Wang, Y.; Patel, D. J. J. Mol. Biol. 1993, 234, 1171.
(5) Parkinson, G. N.; Lee, M. P. H.; Neidle, S. Nature (London) 2002, 417,
876.
(6) Ambrus, A.; Chen, D.; Dai, J.; Bialis, T.; Jones, R. A.; Yang, D. Nucleic
Acids Res. 2006, 34, 2723.
(7) For recent examples see (a) Dixon, I. M.; Lopez, F.; Este`ve, J.-P.; Tejera,
A. M.; Blasco, M. A.; Pratviel, G.; Meunier, B. ChemBioChem 2005, 6,
123. (b) Seenisamy, J.; Bashyan, S.; Gokhale, V.; Vankayalapati, H.; Sun,
D.; Siddiqui-Jain, A.; Steiner, A. N.; Shin-ya, K.; White, E.; Wilson, W.
D.; Hurley, L. H. J. Am. Chem. Soc. 2005, 127, 2944. (c) Teulade-Fichou,
M.-P.; Carrasco, C.; Guittat, L.; Bailly, C.; Alberti, P.; Mergny, J.-L.;
David, A.; Lehn, J.-M.; Wilson, W. D. J. Am. Chem. Soc. 2003, 125,
4732. (d) Schouten, J. A.; Ladame, S.; Mason, S. J.; Cooper, M. A.;
Balasubramanian, S. J. Am. Chem. Soc. 2003, 125, 5594.
(8) Lucke, A. J.; Tyndall, J. D. A.; Singh, Y.; Fairlie, D. P. J. Mol. Graphics
Modell. 2003, 21, 341.
(9) (a) Moore, M. J. B.; Schultes, C. M.; Cuesta, J.; Cuenca, F.; Gunaratnam,
M.; Tanious, F. A.; Wilson, W. D.; Neidle, S. J. Med. Chem. 2006, 49,
582. (b) Ladame, S.; Schouten, J. A.; Stuart, J.; Roldan, J.; Neidle S.;
Balasubramanian, S. Org. Biomol. Chem. 2004, 2, 2925.
(10) Mink, D.; Mecozzi, S.; Rebek, J., Jr. Tetrahedron Lett. 1998, 39, 5709.
(11) Mergny, J.-L.; Maurizot, J.-C. ChemBioChem 2001, 2, 124.
(12) Rezler, E. M.; Seenisamy, J.; Bashyam, S.; Kim, M.-Y.; White, E.; Wilson,
W. D.; Hurley, L. H. J. Am. Chem. Soc. 2005, 127, 9439.
JA064713E
9
J. AM. CHEM. SOC. VOL. 128, NO. 42, 2006 13663